Dan Lyons (aka Fake Steve Jobs) Stands Up For Giz
The battle between Gizmodo and CNBC over Steve Jobs’ health continues to rage on. Obviously, here at Giz AU, we have a distinct bias as to who we think is right, but it’s reassuring to know that Newsweek columnist and ex-Fake Steve Jobs Dan Lyons is prepared to step up to the plate and demand Jim Goldman apologise to Giz. Silicon Alley Insider reckons he’s received a lifetime ban from the channel for it. If that’s the case, we hope Dan knows just how highly we regard him for calling Goldman out. Of course, now that Steve-O ha announced he’s taking sick leave, let’s hope this whole issue can be put to rest so the poor man can get better. Whether you love him, hate him or have no feelings whatsoever for the man or the company he founded, any person dealing with health issues deserves privacy and respect.
- Next Post: AT&T Testing the Waters with American Idol Spam Texts »
- « Previous Post: Eyelash Growing Drug Will Cure That Baldness Around Your Eyes
Comments
you know what they say, and apple a day…. oh wait…. nevermind..
does anyone else find the stupid ticker thingy’s on the bottom and on the side and on the top annoying? dodgy US television hahaha :P
These journalists are scum, Dan Lyons especially. Steve Jobs shouldn’t have a provide any other information apart from that he is taking leave for ‘personal reasons’. CNBC and any other media (including yourselves) should be ashamed of exploiting Steve’s condition.
@ Lloyd: Agreed about reporters, they are scum, however the reason this is an issue is that Steve Jobs is considered to be the ships Captain at Apple, with control on most of the companies directions and image, making his health of significant importance to stakeholders of Apple, which there are many. It is known to almost everyone concerned with Apple that if Steve Jobs isn’t involved in Apple that many shareholders and consumers will pull out. It’s unfortunate that some much rides on one man as he’s not the one who designs anything any more, he just says yay or nay to funding new products within Apples research department.